Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid receptor subunit B, commonly known as GABAB2 or the R2 subunit, forms an obligate heterodimer with the GABAB1 (R1) subunit to create the functional metabotropic GABAB receptor, a class C G protein-coupled receptor (GPCR) that mediates slow inhibitory neurotransmission in the central nervous system. GABAB2 contains an extracellular Venus flytrap domain connected via a unique stalk to a seven-transmembrane domain, with its C-terminus facilitating heterodimerization through a coiled-coil motif and G protein coupling primarily via Gi/o proteins, which inhibit adenylyl cyclase and modulate ion channels like GIRK and voltage-gated calcium channels. This subunit is essential for trafficking the heterodimer to the plasma membrane, as GABAB1 alone is retained in the endoplasmic reticulum, and it hosts allosteric binding sites for positive modulators within the transmembrane domain interface. GABAB receptors, including GABAB2, are implicated in various neurological diseases due to their roles in modulating neuronal excitability presynaptically and postsynaptically. Drugs like baclofen act as orthosteric agonists binding to GABAB1 but require GABAB2 for downstream signaling, while allosteric modulators like GS39783 enhance receptor activity at the GABAB2-involved sites, offering therapeutic potential in conditions such as spasticity, addiction, and pain.
Metabotropic receptor agonist at orthosteric site in Venus flytrap domain of GABAB1 (with GABAB2 required for functional signaling), Positive allosteric modulation at transmembrane domain interface
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit B (GABAB2) (GABAB2).